ANI Pharmaceuticals
ANIP
ANI Pharmaceuticals (ANIP) analyst forecast and price target
Recent analyst ratings
| Firm | Action | Rating | Price target | Date |
|---|---|---|---|---|
| Canaccord Genuity | Maintained | Hold | $90.00 from $91.00 | Aug 10, 2026 |
| Guggenheim | Maintained | Buy | $119.00 from $124.00 | Aug 10, 2026 |
| Canaccord Genuity | Initiated Coverage | Hold | $91.00 | Jul 17, 2026 |
| Guggenheim | Maintained | Buy | $124.00 | Jul 10, 2026 |
| Guggenheim | Maintained | Buy | $124.00 from $115.00 | Jan 16, 2026 |
| Barclays | Initiated Coverage | Overweight | $100.00 | Dec 9, 2025 |
| Guggenheim | Maintained | Buy | $115.00 from $114.00 | Nov 10, 2025 |
| Truist Securities | Maintained | Hold | $90.00 from $77.00 | Oct 9, 2025 |
| JP Morgan | Maintained | Overweight | $115.00 from $95.00 | Sep 24, 2025 |
| HC Wainwright & Co. | Maintained | Buy | $121.00 from $93.00 | Sep 17, 2025 |
| Guggenheim | Maintained | Buy | $114.00 from $86.00 | Sep 8, 2025 |
| Truist Securities | Maintained | Hold | $77.00 from $65.00 | Aug 11, 2025 |
| HC Wainwright & Co. | Maintained | Buy | $93.00 from $84.00 | Aug 8, 2025 |
| HC Wainwright & Co. | Initiated Coverage | Buy | $84.00 | Jul 10, 2025 |
| Guggenheim | Maintained | Buy | $86.00 | May 12, 2025 |
| Truist Securities | Maintained | Hold | $65.00 from $62.00 | Apr 21, 2025 |
| Guggenheim | Maintained | Buy | $86.00 | Apr 11, 2025 |
| HC Wainwright & Co. | Maintained | Buy | $94.00 | Mar 17, 2025 |
| Jefferies | Initiated Coverage | Buy | $80.00 | Mar 14, 2025 |
| JP Morgan | Initiated Coverage | Overweight | $85.00 | Mar 12, 2025 |
Frequently asked questions
What is the latest analyst rating on ANIP?
On Aug 10, 2026, Canaccord Genuity maintained ANI Pharmaceuticals at Hold with a price target of $90.00.
Analyst ratings and price targets are the opinions of third-party research firms, not of Light Horse Securities. They are estimates about an uncertain future, are frequently wrong, and are neither a recommendation nor a prediction of actual results.
This page is for informational purposes only. Nothing on it is a recommendation, solicitation or offer to buy or sell any security, nor investment, legal or tax advice. Light Horse Securities Inc does not verify third-party data and is not responsible for its accuracy, completeness or timeliness.